AI assistant
STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2021
Oct 21, 2021
62616_rns_2021-10-21_c04b4300-677f-434f-8c9e-35915aa22a07.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [144 x 47] intentionally omitted <==
October 21, 2021
BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E) Mumbai - 400 051 Scrip code: 532531 Scrip code: STAR
Dear Sirs,
Sub: Strides announces completion of transaction to acquire manufacturing facility in the US along with basket of ANDAs from Endo International plc
This has reference to our earlier Press Release of August 6, 2021 titled “ Strides inks definitive agreement with Endo to acquire its manufacturing facility in the US along with basket of ANDAs ”.
With reference to above, we wish to inform you that the transaction has now achieved closure.
This is for your information and records.
Thanks & Regards,
For Strides Pharma Science Limited,
==> picture [120 x 49] intentionally omitted <==
Manjula Ramamurthy Company Secretary
==> picture [89 x 88] intentionally omitted <==
==> picture [507 x 51] intentionally omitted <==